|
Gene Information
|
Gene Name
|
PIK3CB |
|
Gene ID
|
5291
|
|
Gene Full Name
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
|
Gene Alias
|
PI3K; PIK3C1; P110BETA; PI3KBETA |
|
Transcripts
|
ENSG00000051382
|
|
Virus
|
HBV |
|
Gene Type
|
protein coding |
|
HPA Location Info
|
Nucleoplasm;Midbody;Nucleoli;Vesicles; 
|
|
HPA Protein Class Info
|
Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins |
|
Uniport_ID
|
P42338
|
|
HGNC ID
|
HGNC:8976
|
|
VEGA ID
|
OTTHUMG00000159893
|
|
OMIM ID
|
602925 |
|
String ID
|
9606.ENSP00000289153
|
|
Drugbank ID
|
BE0002407
|
|
Drug (Cytoscape Annotation)
|
Idelalisib |
|
PharmGKB ID
|
PA33309
|
|
FDA Approved Drug
|
Alpelisib |
Target gene [PIK3CB] related to VISs 
| DVID |
Chromosome |
HM |
TFBS |
CA |
Sum of Overlapped Records |
Detail |
| 1014579 |
chr3 |
2 |
1 |
|
3 |
View |
| 1015406 |
chr3 |
2 |
|
|
2 |
View |
| 1017271 |
chr3 |
1 |
|
|
1 |
View |
Relationship between gene expression and immune infiltrating cell level
| Data ID |
Disease |
Sample number |
Sample type |
|
LIHC (TCGA) |
Liver hepatocellular carcinoma |
424 |
Liver hepatocellular carcinoma HCV (HBV+)(86), Liver hepatocellular carcinoma HCV (HBV-)(19), Liver hepatocellular carcinoma (HBV+)(209), Liver hepatocellular carcinoma (HBV+)(60), Paracancerous HCV (HBV+)(4), Paracancerous (HBV-)(28), Paracancerous (HBV+)(18) |
> Dataset: LIHC
|
|
HeatMap of cell type fractions in all samples
|
Lollipop of PIK3CB expression and immune infiltrating cell level correlation result in HBV+ samples
|
PIK3CB expression: Low -> High
|
|
|
|
|
HBV Target gene Detail Information